A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate 20 Mcg/0.5 mL in the Treatment of Patients With COPD

Dey345 enrolled

Overview

The purpose of this study is to determine the safety and efficacy of the investigational drug in comparison with a placebo.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

345

Conditions

COPD

Interventions

Formoterol FumarateDRUG

Eligibility

Sex: ALLMin age: 40 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Medical diagnosis of COPD * Current or prior history of cigarette smoking Exclusion Criteria: * Medical diagnosis of asthma * Chest X-ray diagnostic of significant disease other than COPD * Significant condition or disease other than COPD

Locations (52)

Outcomes

Primary Outcomes

Measure of lung function

Secondary Outcomes

Change in lung function, as well as vital signs

Physical Exam results, adverse event reporting, etc

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Research Site

Jasper, Alabama, United States

Research Site

Phoenix, Arizona, United States

Research Site

Buena Park, California, United States

Research Site

Costa Mesa, California, United States

Research Site

Huntington Beach, California, United States

Research Site

Long Beach, California, United States

Research Site

San Diego, California, United States

Research Site

Stockton, California, United States

Research Site

Walnut Creek, California, United States

Research Site

Denver, Colorado, United States

...and 42 more locations